"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
| Descriptor ID |
D018450
|
| MeSH Number(s) |
C23.550.291.656
|
| Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 7 | 7 |
| 1997 | 0 | 10 | 10 |
| 1998 | 0 | 14 | 14 |
| 1999 | 0 | 24 | 24 |
| 2000 | 0 | 22 | 22 |
| 2001 | 0 | 29 | 29 |
| 2002 | 0 | 23 | 23 |
| 2003 | 0 | 49 | 49 |
| 2004 | 0 | 31 | 31 |
| 2005 | 0 | 40 | 40 |
| 2006 | 0 | 39 | 39 |
| 2007 | 0 | 52 | 52 |
| 2008 | 0 | 45 | 45 |
| 2009 | 4 | 50 | 54 |
| 2010 | 4 | 54 | 58 |
| 2011 | 9 | 61 | 70 |
| 2012 | 4 | 64 | 68 |
| 2013 | 4 | 62 | 66 |
| 2014 | 6 | 62 | 68 |
| 2015 | 11 | 86 | 97 |
| 2016 | 6 | 72 | 78 |
| 2017 | 7 | 85 | 92 |
| 2018 | 7 | 92 | 99 |
| 2019 | 10 | 105 | 115 |
| 2020 | 5 | 85 | 90 |
| 2021 | 8 | 64 | 72 |
| 2022 | 0 | 37 | 37 |
| 2023 | 0 | 42 | 42 |
| 2024 | 18 | 39 | 57 |
| 2025 | 5 | 61 | 66 |
| 2026 | 0 | 33 | 33 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
Glyoxalase 1 promotes glioma progression by modulating Sox2 transcriptional networks in glioma stem-like cells. Neuro Oncol. 2026 Jul 01; 28(7):1680-1693.
-
Accounting for Age-Related Increases in HbA1c More Accurately Quantifies Risk of Type 1 Diabetes Progression in Islet Autoantibody-Positive Adults. Diabetes Care. 2026 Jul 01; 49(7):1262-1269.
-
Correlates of 5-year decline in 6-min walk distance in the COPDGene cohort. Thorax. 2026 Jun 15; 81(7):664-671.
-
Ambulatory Stage C2D Heart Failure Definitions and Current Therapeutic Approaches: JACC: Heart Failure Position Statement. JACC Heart Fail. 2026 Jun; 14(6):103101.
-
Cardiac Resynchronization Therapy: A Review. JAMA. 2026 May 26; 335(20):1796-1807.
-
Growing teratoma syndrome of the ovary: a case series. J Med Case Rep. 2026 May 24; 20(1).
-
Obesity in CKD: Core Curriculum 2026. Am J Kidney Dis. 2026 Jul; 88(1):142-153.
-
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials. Lancet. 2026 May 23; 407(10543):2027-2039.
-
Cigarette smoke induces FASN-dependent fatty acid metabolic rewiring to drive bladder cancer progression. Cancer Lett. 2026 Aug 10; 653:218562.
-
Differences in gene expression may contribute to the racial differences in the risk of MASLD. PLoS One. 2026; 21(5):e0345383.